Fibrosis Program(s)

About Focal Biosciences

Focal Biosciences is an early-stage biotech leveraging its proprietary CFC (Chromatin Fingerprint for Cell state)-Platform to discover drugs that reprogram diseased cells. The company integrates AI, machine learning, and tissue-mimicking disease models to target the chromatin landscape, with an immediate focus on fibrotic diseases and a broader vision for age-related chronic conditions. As a private, pre-revenue company likely in the pre-clinical stage, it is seeking collaborations and investment to advance its transformative approach to drug discovery.

Therapeutic Areas

Other Fibrotic diseases Drugs